Russell Investments Group’s Albireo Pharma Inc ALBO Stock Holding History

Russell Investments Group’s Portfolio ALBO Stock Details ALBO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-21,662	Closed	-$468K	–	3430
2022 Q4	$468K	Buy	21,662 +20,886	+2,691%	+$441K	﹤0.01%	2313
2022 Q3	$15K	Hold	776	–	–	﹤0.01%	2838
2022 Q2	$15K	Sell	776 -462	-37%	-$12.2K	﹤0.01%	2824
2022 Q1	$36K	Buy	+1,238	New	+$36.2K	﹤0.01%	2649

Other funds holding ALBO

DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return

GKIM

GW&K Investment Management Boston, Massachusetts $11.3B AUM 31.98% 1-Year Est. Return

HNB

Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Russell Investments Group's ALBO Position: Q1 2023 in Review

Russell Investments Group sold out of Albireo Pharma Inc (ALBO) in Q1 2023, closing a stake of 21,662 shares — an estimated $468K sold.

Russell Investments Group first reported a position in ALBO in Q1 2022 and held it in 4 quarters. The position peaked at $468K in Q4 2022. 3 funds tracked by Wall St. Rank hold ALBO as of Q1 2023.

Russell Investments Group reported no remaining Albireo Pharma Inc position as of Q1 2023 after selling out during the quarter.
Russell Investments Group sold 21,662 Albireo Pharma Inc shares in Q1 2023, an estimated $468K.
Russell Investments Group first reported a position in Albireo Pharma Inc in Q1 2022 and held it in 4 quarters.
Russell Investments Group's Albireo Pharma Inc position peaked at $468K in Q4 2022.
3 funds tracked by Wall St. Rank held Albireo Pharma Inc as of Q1 2023.

Based on Russell Investments Group's 13F filing for Q1 2023, filed 9 May 2023.